NIH-funded research R01 grant

Prenatal gene therapy approach to prevent cleft lip and palate in a human-like mouse model

Official title: In utero rescue of cleft lip and palate in a humanized mouse model

Funded at University of Colorado Denver · NIH-11261221 · Data updated 2026-11-12

The team is trying a prenatal gene-delivery approach in humanized mice to prevent cleft lip and palate linked to TFAP2A mutations, with the goal of helping babies born with those conditions.

More Cleft Lip and Palate research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$435,364
NIH project number5R01DE032740-04
Project IDNIH-11261221 on NIH RePORTER

Who could benefit from this research

Could help

The work is most relevant to families affected by TFAP2A-related syndromes (such as Branchio-Oculo-Facial Syndrome) or those with a known TFAP2A mutation who might be candidates if human trials are developed.

Less likely to help

People whose cleft lip or palate is caused by other genes or non-genetic/environmental factors would be less likely to benefit from a TFAP2A-targeted prenatal approach.

What this research studies

Researchers are using mice engineered to mimic human TFAP2A-related cleft lip and palate to test a prenatal corrective therapy. They deliver a gene-carrying AAV vector into the developing embryo before birth and follow facial development to see if clefts are prevented. The team examines both anatomical outcomes and safety signals in treated animals. Findings will guide whether this approach could move toward future prenatal treatments for at-risk pregnancies.

Why it matters

Potential benefit: If successful, this could point toward prenatal treatments that prevent or reduce cleft lip and palate in babies with TFAP2A-related conditions.

How similar studies have gone: Some prenatal gene-delivery approaches have corrected defects in animal models, but in utero rescue specifically for TFAP2A-linked craniofacial clefts is largely novel.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Williams, Trevor J — University of Colorado Denver
  • Study coordinator: Williams, Trevor J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.